← Latest news 
EQT becomes sole bidder for OmniActive Health Technologies after rival offers fail
Business
Published on 8 May 2026
A rejected bid leaves EQT holding the only ticket
Swedish investment firm EQT has emerged as the sole bidder for OmniActive Health Technologies after the company rejected a competing offer from Temasek and Novo Holdings. OmniActive, backed by TA Associates, has a strong position in nutraceuticals and a notable export footprint in the United States, making the sale a key development for the sector.
- EQT is now the exclusive bidder for OmniActive
- Temasek and Novo Holdings offer was rejected
- OmniActive has a strong nutraceutical and US export presence
- Company is under TA Associates
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times